Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. - Wikidata - awgldk - TriplyDB

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

http://www.wikidata.org/entity/Q44499780

about

microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells Can routine commercial cord blood banking be scientifically and ethically justified?Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies Cord Blood as a Source of Natural Killer Cells Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning Alternative Donor Transplantation for Acute Myeloid Leukemia Umbilical cord blood transplantation for the treatment of hematologic malignancies Cord blood graft engineering Advances in umbilical cord blood manipulation-from niche to bedside Advances in predicting acute GVHD Outcomes from unrelated donor hematopoietic stem cell transplantation Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments IL-7 in allogeneic transplant: clinical promise and potential pitfalls Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy.Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors.Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit.Cellular-based therapies to prevent or reduce thrombocytopenia.Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank.Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?Quality rather than quantity: the cord blood bank dilemma.The Mannheim Cord Blood Bank: Experiences and Perspectives for the Future.Reasons for exclusion of 6820 umbilical cord blood donations in a public cord blood bank.Transplant outcomes in acute leukemia. I.Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trial Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.Current and future approaches for control of graft-versus-host disease.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms The density of CD10 corresponds to commitment and progression in the human B lymphoid lineage.Engineering cord blood to improve engraftment after cord blood transplant.Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy

P2860

Q24648506-C30A5601-1A86-4011-85B2-15F4A912DDDF Q24794518-3FBC09F1-9B63-47F0-8420-ED7FD7A16434 Q26738469-F68AFBD2-38CB-4CC5-9314-17F2E0582106 Q26751959-BF9D53E8-FEC7-4A53-B05C-6DE3BDE0E45E Q26771337-174EF131-1671-4BB6-859F-4E82564C46E7 Q26795740-3D6AEF51-A530-4E78-B8C3-287F7E4D1739 Q26799456-4300CC79-861C-4398-9FD8-7AD8087C9CD7 Q26820829-AE197D25-CF58-480A-AFC0-A466F3D2360F Q26822376-AD43F422-8363-474D-86F5-4D84981647E5 Q26824305-044DD563-0ED3-44EF-AE3E-439291401EAF Q27021123-6A2B0329-B5CE-46EF-86DF-269A299139C4 Q27027854-2DDF70EE-F1FD-4ECD-B5ED-20D8E5C3AD57 Q27307742-5213A38F-C93E-4A9F-B80D-5701B3530B1D Q28066500-E155A422-3A7C-452F-BB63-49933B5CC0D7 Q28067102-FED7C8DC-2968-4A6E-9587-005F4E781E8E Q28259144-8F6D6BCE-9272-4DC4-9F36-515438767973 Q28727639-1BACA7FA-5F7B-4AFF-B79B-C18415CFA4DF Q30399209-519E26EB-4FAC-47C0-8C05-4619C5C939EC Q30418861-073830EC-653B-4593-B6A8-15709CF66CAE Q30423085-6D6196BA-5E98-4E05-81CB-ED7466A64124 Q30424777-6480D307-5324-4349-A905-A100C9E67609 Q33296300-CC312B05-80F6-43EC-97E5-B7FE5179B3D9 Q33372906-7FFD0E51-B0C5-4777-932A-957DF9C86630 Q33398164-FB445197-6722-46E0-BF65-92026F50A4D5 Q33441641-26D0CCA8-8928-4CB9-B971-32CB90245325 Q33449843-DBE5E73B-C644-4F33-B259-DAFA2B127251 Q33451570-4458B605-5A25-4A06-8BFC-48A583B8B440 Q33452269-394F1A6E-61AF-4272-B4A0-A2E840930069 Q33452872-7774A7BB-DFF8-4934-B9B9-E5EA633E6126 Q33455702-4267DD06-70FC-4A7B-A1BA-4A508AA47DF4 Q33621502-F63E0B6F-94BF-457A-B925-2A11122C0499 Q33624406-956327F1-26CA-4AEE-8EC3-0E322468CF5F Q33627040-8E8279EE-5713-4046-B4D2-0DB6A4B306E1 Q33642625-3256247B-D3F5-4EB0-B79D-F852B61E7109 Q33685495-39B40436-8574-4C88-889F-DFA9D5F6A784 Q33705051-E1668E6C-461F-41D2-A262-AAA3F16B807C Q33707714-79B91D1F-FBF0-482D-AC75-30BD23C575B1 Q33766995-796A775A-86A0-4E7E-BFBF-3C0C9997596E Q33767001-BCE751D4-68FC-4B90-B5A6-8F65EF4AE39A Q33800639-92034B7C-682B-4985-A864-2BEAA77BB93C

P2860

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

http://www.wikidata.org/entity/Q44499780

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Outcomes after transplantation ...... onors in adults with leukemia.

@en

Outcomes after transplantation ...... onors in adults with leukemia.

@nl

type

label

Outcomes after transplantation ...... onors in adults with leukemia.

@en

Outcomes after transplantation ...... onors in adults with leukemia.

@nl

prefLabel

Outcomes after transplantation ...... onors in adults with leukemia.

@en

Outcomes after transplantation ...... onors in adults with leukemia.

@nl

P1433

Q44499780-E6FF51C9-93FA-4AD6-B1C7-DBD53F72C948

P1476

Q44499780-3C51BA67-423C-40C1-BCC1-35D371F7B4E2

P2093

Q44499780-059B6599-664F-4C7F-9A9A-AEC686A5C9AD

Q44499780-18678D61-2D9B-403F-8EA5-313C576B6560

Q44499780-189E8356-FE1D-4A08-A0EB-CF88D592C46B

Q44499780-34A1801F-FAB7-4669-8980-C138DEA901F5

Q44499780-39918E70-F08C-4440-945C-5230650EF1BA

Q44499780-39CE97A6-574D-4C13-8A4C-2BD063E7BF1A

Q44499780-3D8C8EF6-7021-4A3A-BDDB-B46EEB54A936

Q44499780-3DB2103F-BFC6-48AD-8EA7-6D98EBE526CF

Q44499780-65A3323F-7116-4EAE-9109-58B646FD534E

Q44499780-7C5B41C1-3C31-44B6-8CAC-0F78356D3EB3

P304

Q44499780-AE81FFF3-F21F-4E5D-9FD2-ADDC1EF844AA

P31

Q44499780-999BF41E-0F66-4FDB-8C2E-D910DA9A0123

P356

Q44499780-FD737072-6F00-4B9C-B95B-C8B336399A28

P407

Q44499780-F3FF2525-830D-409E-8C77-8A88E37EC07A

P433

Q44499780-22BCA96F-E779-4D2D-BCF9-EE28C48667D4

P478

Q44499780-CB587F3C-6385-4849-9E5F-C6AB4C1BA31A

P50

Q44499780-16FCB294-41AE-4427-830A-BBEF65772ABD

Q44499780-3A0F221C-51E9-42B9-B335-1F4B3E220ED9

P577

Q44499780-73A29A35-C2B5-4490-999A-47A68CD539F9

P698

Q44499780-EDE1AB1A-DE7C-4EFD-82E8-6ECF07F227F1

P921

Q44499780-C9130F2F-F688-4D47-B544-8DD99C0587DD

Q44499780-EAC62CAD-746B-4B1A-8445-A1A62B710FEA

P356

P1433

The New England Journal of Medicine

P1476

Outcomes after transplantation ...... onors in adults with leukemia.

@en

P2093

Andromachi Scaradavou

http://www.w3.org/2001/XMLSchema#string

Cladd Stevens

http://www.w3.org/2001/XMLSchema#string

David I Marks

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

Jon J van Rood

http://www.w3.org/2001/XMLSchema#string

Juliet N Barker

http://www.w3.org/2001/XMLSchema#string

Mary Eapen

http://www.w3.org/2001/XMLSchema#string

Mary J Laughlin

http://www.w3.org/2001/XMLSchema#string

Mary M Horowitz

http://www.w3.org/2001/XMLSchema#string

Mei-Jei Zhang

http://www.w3.org/2001/XMLSchema#string

P304

2265-2275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA041276

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P50

Robert Peter Gale

Hillard M Lazarus

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15564543

http://www.w3.org/2001/XMLSchema#string

P921